CHEBI:133010 - Odefsey

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name Odefsey ChEBI ID CHEBI:133010 Definition A three-drug mixture comprising emtricitabine, rilpivirine hydrochloride and tenofovir alafenamide fumarate; used as a complete regimen for the treatment of HIV-1 infection. Stars This entity has been manually annotated by the ChEBI Team. Roles Classification Biological Role(s): antiviral drug A substance used in the prophylaxis or therapy of virus diseases. HIV-1 reverse transcriptase inhibitor An entity which inhibits the activity of HIV-1 reverse transcriptase. Application(s): antiviral drug A substance used in the prophylaxis or therapy of virus diseases. View more via ChEBI Ontology ChEBI Ontology Outgoing Odefsey (CHEBI:133010) has part emtricitabine (CHEBI:31536) Odefsey (CHEBI:133010) has part rilpivirine hydrochloride (CHEBI:68602) Odefsey (CHEBI:133010) has part tenofovir alafenamide fumarate (CHEBI:90923) Odefsey (CHEBI:133010) has role antiviral drug (CHEBI:36044) Odefsey (CHEBI:133010) has role HIV-1 reverse transcriptase inhibitor (CHEBI:53756) Odefsey (CHEBI:133010) is a mixture (CHEBI:60004) Synonyms Sources Emtricitabine and rilpivirine and tenofovir alafenamide ChemIDplus Emtricitabine mixture with rilpivirine and tenofovir alafenamide ChemIDplus Emtricitabine/rilpivirine/tenofovir alafenamide ChemIDplus FTC/RPV/TAF ChemIDplus R/F/TAF ChemIDplus Citation Type Source 27148923 PubMed citation Europe PMC Last Modified 15 August 2016

General Comment 2016-08-15 This mixture has a ChemIDplus substance accession number S900007090.